Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Antibiotic resistance - what can we do?

Nature Medicine volume 4, pages 545–546 (1998)Cite this article

The Brockham Group was convened to investigate the growing problem of antibiotic resistance and to develop a strategy to improve our understanding and management of this phenomenon. Here they present their recommendations.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. WHO Scientific Working Croup on Monitoring and Management of Bacterial Resistance to Antimicrobial Agents. WHO, Geneva WHO/CDS/BV I 7,1–33 (1995).

  2. Cohen, M.L. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257,1050–1055 (1992).

    Article  CAS  Google Scholar 

  3. Tomasz, A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University workshop. N. Engl. j. Med. 330,1247–1251 (1994).

    Article  CAS  Google Scholar 

  4. Felmingham, D., Gruneberg, R.N. & The Alexander Project Group. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: j. Antimicrob. Chemother. 38, suppl A: 1–57 (1996).

    Article  CAS  Google Scholar 

  5. Tomasz, A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University workshop. N. Engl. j. Med. 330,1247–1251 (1994).

    Article  CAS  Google Scholar 

  6. Klugman, K.P. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents for the treatment of community-acquired pneumonia. J. Antimicrob. Chemother. 38, suppl A: 133–140 (1996).

    Article  CAS  Google Scholar 

  7. Seppala, H. et al. Finish study group for antimicrobial resistance. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. j Med. 337,441 (1997).

    Article  CAS  Google Scholar 

  8. Pallares, R. et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333,474–80 (1995).

    Article  CAS  Google Scholar 

  9. Pinner, W.R. et al. Trends in infectious diseases mortality in the United States. IAMA 275,189–93(1996).

    Article  CAS  Google Scholar 

  10. Sack, R.B., Rahman, M., Yunus, M. & Khan, E.H. Antimicrobial resistance in organisms causing diarrheal disease. Clin. Inf. Dis. 24, suppl 1: SI 02–5 (1997).

    Google Scholar 

  11. Bax, R.P. Antibiotic resistance: A view from the pharmaceutical industry. Clin. Inf. Dis. 24, suppl 1: SI51–3 (1997).

    Article  Google Scholar 

  12. Chopra, I., Hodgson, J., Metcalf, B., Poste, G. New approaches to the control of infections caused by antibiotic-resistant bacteria. An Industry Perspective. IAMA 275, 401–3(1996).

    Article  CAS  Google Scholar 

  13. Nystrom, P.O. et al. Proposed definitions for diagnosis, severity scoring, stratification and outcome for trials on intra abdominal infection. World. J. Sura 14,148–58 (1990).

    Article  CAS  Google Scholar 

  14. Bax, R.P. Clinical trials and the pharmaceutical industry. J. Antimocrob. Chemother 21,278–80(1988).

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. R.P. Bax: Correspondence to R. P. B

Authors and Affiliations

  1. SmithKline Beecham Pharmaceuticals, Third Avenue, Harlow, Essex, UK, CM19 5AW

    R.P. Bax, R. Anderson, J. Crew, P. Fletcher, T. Johnson, E. Kaplan, B. Knaus, K. Kristinsson, M. Malek & L. Strandberg

Authors
  1. R.P. Bax
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Crew
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Fletcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Kaplan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Knaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. Kristinsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Malek
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. L. Strandberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bax, R., Anderson, R., Crew, J. et al. Antibiotic resistance - what can we do?. Nat Med 4, 545–546 (1998). https://doi.org/10.1038/nm0598-545

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0598-545

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing